Company: AGIO
Filing Date: 2025-07-31
Form Type: 10-Q
Source: 0001439222-25-000089
Chunk: 128

Company: AGIOS PHARMACEUTICALS, INC.
Filing Date: 2025-07-31
Form: 10-Q
Item: Part I, Item 1
Chunk 128
---
 to sales in the current year733 1,298 256 2,287 Adjustments relating to prior years(51)(83)— (134)Payments/returns relating to sales in the current year(610)(428)— (1,038)Payments/returns relating to sales in the prior years(202)(462)— (664)Balance at June 30, 2025$123 $1,679 $745 $2,547 Total revenue-related reserves above, included in our condensed consolidated balance sheets, are summarized as follows:(In thousands)June 30, 2025December 31, 2024Reduction of accounts receivable$104 $124 Component of accrued expenses 2,443 1,972 Total revenue-related reserves$2,547 $2,096 The following table presents changes in our contract assets during the six months ended June 30, 2025:(In thousands)December 31, 2024AdditionsDeductionsJune 30, 2025Contract assets(1)Accounts receivable, net$4,109 $23,333 $(22,456)$4,986 

(1)  Additions to contract assets relate to amounts billed to Customers for product sales and deductions to contract assets primarily relate to collection of receivables during the reporting period. 

12

9. Share-Based Payments

2023 Stock Incentive Plan and Inducement GrantsIn June 2023, our stockholders approved the 2023 Stock Incentive Plan, or the 2023 Plan. The 2023 Plan provides for the grant of incentive stock options, nonstatutory stock options, stock appreciation rights, restricted stock awards, restricted stock units, or RSUs, performance-based share units, or PSUs, and other stock-based awards to employees, advisors, consultants and non-employee directors. Following the adoption of the 2023 Plan, we ceased granting equity awards under the 2013 Stock Incentive Plan, or the 2013 Plan. Any outstanding equity awards that were previously granted under the 2013 Plan continue to be governed by their terms. Following adoption of the 2013 Plan, we ceased granting equity awards under the 2007 Stock Incentive Plan, or the 2007 Plan. There are no outstanding equity awards under the 2007 Plan.In connection with the start of employment of our Chief Executive Officer and Chief Financial Officer in 2022